Newsroom

BOCA RATON, Fla.--(BUSINESS WIRE)--SBA Communications Corporation (Nasdaq: SBAC) ("SBA" or the "Company") today reported results for the quarter ended March 31, 2026. Highlights of the first quarter include: Net income attributable to SBA of $184.8 million or $1.74 per share Industry-leading AFFO per share of $3.03 Increased full year 2026 outlook across all key metrics Company-wide Tower Cash Flow margin of approximately 80% In addition, the Company announced today that its Board of Directors...

LIVERMORE, Calif.--(BUSINESS WIRE)--McGrath RentCorp (“McGrath” or the “Company”) (Nasdaq: MGRC), a leading business-to-business rental company in North America, today announced total revenues for the quarter ended March 31, 2026 of $198.5 million, an increase of 2% compared to the first quarter of 2025. The Company reported net income of $27.0 million, or $1.10 per diluted share, for the first quarter of 2026, compared to net income of $28.2 million, or $1.15 per diluted share, for the first q...

阿拉伯聯合大公國，杜拜--(BUSINESS WIRE)--(美國商業資訊)-- 杜拜Medcare皇家專科醫院 (MRSH) 成為全球第一所在美國境外地區使用新核准的鞘內基因療法「Itvisma」治療罹患脊髓性肌肉萎縮症 (SMA) 之成人患者的醫院。這種單次給藥的療法最近施用於一名22歲的埃及患者身上。他在18個月大時確診，不得不在輪椅上度過一生中的大部分時間。 Medcare也在去年成為全球第一所使用新核准之「Itvisma」療法治療一名四歲大SMA國際患者的醫療供應者。 SMA是一種罕見的神經肌肉疾病，會導致慢性惡化的肌肉無力並喪失活動能力，影響運動、呼吸及吞嚥功能。過去治療SMA的基因療法主要針對兩歲以下的病童而開發。現在，Medcare利用新核准的基因療法治療兩歲以上的患者。 在提到這項先進療法時，Medcare醫院與醫藥中心集團執行長Shanila Laiju醫師說：「我們深信將SMA治療對象擴及成人可以改變中東及更廣大地區數千人的生活。Medcare能夠引入Itvisma療法，是因為我們擁有率先治療較年長SMA患者所奠定的基礎，其成就已獲得Novartis的肯定。全球每...

アラブ首長国連邦ドバイ--(BUSINESS WIRE)--（ビジネスワイヤ） -- ドバイのメドケア・ロイヤル・スペシャリティ病院（MRSH）は、米国以外では初めて、新たに承認された髄腔内遺伝子治療薬「イトビスマ」を成人脊髄性筋萎縮症（SMA）患者に投与した病院となりました。この1回限りの治療は最近、生後18か月で診断を受け、人生のほとんどを車椅子で過ごしてきた22歳のエジプト人患者に対して行われました。 昨年メドケアは、新たに承認されたイトビスマを4歳の外国人SMA患者に世界で初めて投与した病院です。 SMAは、進行性の筋力低下と運動機能の喪失を引き起こし、運動、呼吸、嚥下に影響を与える希少な神経筋疾患です。これまで、SMAの遺伝子治療の進歩は主に2歳未満の小児に限られていました。メドケアは、新たに承認された遺伝子治療薬を用いて、2歳以上の患者にも治療を提供できるようになりました。 メドケア病院・医療センターグループCEOのシャニラ・ライジュ医師は、この先進的な治療法について、「成人に対するSMA治療の拡大は、中東地域をはじめとする世界各地で何千人もの人々の人生を変えることができ...

DUBAI, Emirados Árabes Unidos--(BUSINESS WIRE)--O Medcare Royal Speciality Hospital (MRSH), em Dubai, tornou-se o primeiro hospital fora dos Estados Unidos a oferecer a terapia gênica intratecal Itvisma, recentemente aprovada, a pacientes adultos com atrofia muscular espinhal (AME). Esse tratamento exclusivo foi recentemente administrado a um paciente egípcio de 22 anos, diagnosticado aos 18 meses de idade, que está confinado a uma cadeira de rodas há muito tempo. No ano passado, o Medcare se t...

阿拉伯联合酋长国迪拜--(BUSINESS WIRE)--(美国商业资讯)-- 迪拜Medcare皇家特殊病医院（MRSH）成为全球首个为成人脊髓性肌萎缩症（SMA）患者提供新获准上市的鞘内基因疗法（Itvisma）的非美国医院。最近该院为一名22岁的埃及患者提供了这种一次性的治疗。这名患者已确诊该疾病18个月，人生大部分时间都不得不在轮椅上度过。 去年，Medcare成为全球首个为一名四岁国际SMA患者提供新获准上市的Itvisma的医疗服务机构。 SMA是一种罕见的神经肌肉疾病，会导致肌肉逐渐变弱并失去行动能力，影响行动、呼吸和吞咽。直到目前，SMA基因疗法的进步主要限于两岁以下儿童。Medcare现为可为两岁以上的患者提供新获批基因疗法治疗。 对于这项先进治疗，Medcare医院及医学中心集团首席执行官Shanila Laiju指出：“我们相信将SMA治疗扩展到成年人可以改变中东乃至全球数千人的生命。经诺华公司认可，Medcare引进Itvisma强化了我们在治疗更高年龄SMA患者领域的探索者角色。全球10,000名新生儿中有1名不幸罹患SMA，DMD更影响着全球300,000男...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 6, 2026...

SEATTLE--(BUSINESS WIRE)--Amazon.com, Inc. (NASDAQ: AMZN) today announced financial results for its first quarter ended March 31, 2026. Net sales increased 17% to $181.5 billion in the first quarter, compared with $155.7 billion in first quarter 2025. Excluding the $2.9 billion favorable impact from year-over-year changes in foreign exchange rates throughout the quarter, net sales increased 15% compared with first quarter 2025. North America segment sales increased 12% year-over-year to $104.1...

TORONTO--(BUSINESS WIRE)--Primaris Real Estate Investment Trust (“Primaris” or “the Trust”) (TSX: PMZ.UN) announced today financial and operating results for the first quarter ended March 31, 2026. Financial and Operating Results Highlights $177.0 million total rental revenue; $734 per square foot total same stores sales productivity; -2.1% change in Same Properties Cash Net Operating Income** ("Cash NOI") growth (or +1.7% excluding the $2.5 million prior year property tax recoveries recorded i...

NEW YORK & IRVINE, Calif.--(BUSINESS WIRE)--BSH Home Appliances Group, a global leader in home appliances and a division of the Bosch Group, today reported its fiscal year 2025 business results for Region North America, highlighting regional revenue growth of more than 5% in U.S. dollar terms and continued outperformance of the broader market. Darcy Clarkson, CEO of BSH Region North America, shared the results and a 2026 outlook with the media at an exclusive event in New York City. The North A...